Short answer
Definium Therapeutics, Inc. (DFTX) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Full-year fiscal 2025 results announced Feb 26, 2026; details in Exhibit 99.1 press release.
Definium Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Full-year fiscal 2025 results announced Feb 26, 2026; details in Exhibit 99.1 press release
- Conference call scheduled to discuss FY2025 financials and recent corporate highlights: key event for forward guidance signals
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Definium Therapeutics, Inc. 8-K filings
Get the next DFTX 8-K as it lands
Follow DFTX for push alerts, or ask the research agent what this filing means.